Human NDR1 and 2 (NDR1/2) are serine-threonine protein kinases in a subgroup of the AGC kinase family [1] . The mechanisms of physiological NDR1/2 activation and their function remain largely unknown. Here we report that Fas and TNF-a receptor stimulation activates human NDR1/2 by promoting phosphorylation at the hydrophobic motif (Thr444/442). Moreover, NDR1/2 are essential for Fas receptor-induced apoptosis as shown by the fact that NDR knockdown significantly reduced cell death whereas overexpression of the NDR1 kinase further potentiated apoptosis. Activation of NDR1/2 by death receptor stimulation is mediated by the tumor suppressor RASSF1A. Furthermore, RASSF1A-induced apoptosis largely depends on the presence of NDR1/2. Fas receptor stimulation promoted direct phosphorylation and activation of NDR1/2 by the mammalian STE20-like kinase 1 (MST1), a downstream effector of RASSF1A. Concurrently, the NDR1/2 coactivator MOB1 induced MST1-NDR-MOB1 complex formation, which is crucial for MST1-induced NDR1/2 phosphorylation upon induction of apoptosis. Our findings identify NDR1/2 as novel proapoptotic kinases and key members of the RASSF1A/MST1 signaling cascade.
Apoptotic pathways, including those induced by death receptors, are often suppressed in cancer cells through the inactivation of corresponding tumor suppressors, which normally resist cell overgrowth [2] [3] [4] . RASSF1A (Ras association domain family 1 isoform A) is a well-known tumor suppressor protein encoded by a gene on human chromosome 3 at p21.3 and is often silenced by promoter hypermethylation in a wide variety of human cancers [2, 5] . Reintroduction of RASSF1A was reported to induce cell-cycle inhibition via inactivation of the APC/Cdc20 complex [6] or apoptosis via MST1 or MST2 [7, 8] . Although MST2 is known to signal through LATS1/2 [8] [9] [10] , the apoptotic signaling cascade downstream of MST1 in mammalian cells remains obscure.
NDR1/2 are serine-threonine protein kinases belonging to an AGC kinase subfamily implicated in many essential processes such as cell division and proliferation [1] . So far the only known function implicates NDR1 in the regulation of centrosome duplication [11] . Two phosphorylation sites of human NDR1/2, Ser281/282 and Thr444/442, are essential for full kinase activation in vitro and in vivo [12, 13] . The binding of coactivator MOB1A to the N terminus of NDR1/2 stimulates kinase activity, which results in autophosphorylation on Ser281/282 at the activation segment [14] .
We reported earlier that MST3 kinase can phosphorylate NDR1/2 at Thr444/442 in the hydrophobic motif [15] . Although no physiological stimulus has been reported for the MST3 kinase, close members within the MST kinase family, such as MST1 and MST2, are actively involved in apoptosis and stress response [16] [17] [18] [19] [20] . To determine whether NDR1/2 are regulated by apoptotic stimuli, we treated HeLa cells with the Fas antibody or TNF-a. We observed a robust induction of NDR1/2 phosphorylation at Thr444/442, but total NDR1/2 did not change. This NDR1/2 phosphorylation was paralleled by activation of MST1/2 and by PARP cleavage, confirming the onset of apoptosis ( Figure 1A , top). Similar results were obtained with Jurkat cells (Figure S1A available online). The kinase activity of endogenous NDR1/2 increased significantly (more than 8-fold) in cells undergoing Fas and TNF-a receptor stimulation, indicating NDR1/2 activation during apoptosis ( Figure 1A , bottom). These data are the first indication of a physiological stimulation of NDR kinases.
It has been reported that Fas receptor stimulation triggers RASSF1A-dependent activation of the downstream signaling cascade [7, 8] . Indeed, expression of RASSF1A was sufficient to promote NDR1/2 activation, comparable to induction by the Fas receptor ( Figure 1B, top) . Moreover, localization of activated NDR1/2 and RASSF1A partially overlapped in the cytoplasm ( Figure 1B, bottom) . Decreased levels of RASSF1A protein in cells treated with the Fas antibody resulted in impaired NDR Thr444/442 phosphorylation, indicating that the Fas-dependent apoptotic signaling cascade activating NDR kinases is mediated by RASSF1A ( Figure 1C) .
RASSF1A protein was shown to exert its proapoptotic effects via MST1 and MST2 kinases [7, 8, 21] . In Fas receptorinduced apoptosis, MST2 transmits an apoptotic signal to LATS1; however, no downstream target of MST1 has yet been proposed. To investigate whether MST1 is involved in the regulation of NDR Thr444/442 phosphorylation, the level of the endogenous MST1 kinase was decreased by shRNA. Stimulation of NDR Thr444/442 phosphorylation upon Fas antibody treatment failed in cells with low MST1 content ( Figure 1D ), demonstrating the importance of MST1 for the NDR1/2 activation during apoptosis. Transient knockdown of MST2 resulted in only moderate downregulation of NDR1/2 phosphorylation under the same experimental conditions ( Figure S1B ). Consistent with these data, we also found reduced NDR Thr444/442 phosphorylation triggered by the expression of RASSF1A in MST1 knockdown cells ( Figure 1E ). In addition, NDR1/2 kinase activity was stimulated by the nonspecific inducer of apoptosis, actinomycin D ( Figure S1C ). Knockdown of MST1 efficiently prevented NDR1/2 phosphorylation, induced by actinomycin D, whereas knockdown of MST3 did not change the level of phosphorylated NDR ( Figure S1D ).
Because MST1 kinase was crucial for the activation of NDR1/2 during apoptosis, we tested its ability to induce NDR1 activation in a series of kinase assays. MST1, but not its kinase dead variant, phosphorylated MBP-NDR1 protein in vitro (Figure 2A, left) . Next, we confirmed that MST1 was able to directly phosphorylate MBP-NDR1 at the hydrophobic motif (Thr444) (Figure 2A , top right), raising the question of whether this phosphorylation also induced NDR1/2 activation. Indeed, NDR1 phosphorylated at Thr444 by MST1 displayed greatly (7-fold) enhanced protein kinase activity ( Figure 2A , bottom right). In order to verify the specificity of the kinase reaction, we performed experiments with recombinant MST1 (Figures S2A and S2B) . Finally, we determined whether MST2 and MST4 are also potential upstream kinases for NDR. Although MST1, MST2, and MST3 potently activated NDR1 in vitro, MST4 had only a minor effect ( Figure S2C) . The contribution of MST1 to in vivo phosphorylation and activation of NDR was studied by expressing the kinase in HEK293 cells. MST1 induced significant phosphorylation of NDR1/2 on Thr444/442 ( Figure 2B ), comparable with that induced by RASSF1A expression ( Figure 1B ), Fas antibody, or TNF-a treatment ( Figure 1A ). Next, we examined whether the observed increase in NDR Thr444/442 phosphorylation was mediated by RASSF1A-MST1 binding via their SARAH domains [7, 22] . As expected, wild-type MST1 coimmunoprecipitated with RASSF1A, whereas the MST1 mutant lacking the SARAH domain (DSAR) as well as MST3 (naturally lacking a SARAH domain) failed to bind RASSF1A ( Figure S2D) . Comparison of NDR1/2 phosphorylation in cells expressing wild-type or SARAH domain-deletion variants (DSAR) of RASSF1A, MST1, or their combination showed that interaction of RASSF1A and MST1 is required for a positive effect on NDR Thr444/442 phosphorylation ( Figure 2C ).
Our data place mammalian NDR1/2 directly downstream of the MST1 kinase. In Drosophila, the ortholog of NDR (Trc), as well as of LATS (Warts/Lats), are also regulated by MST (Hpo), a core member of Hippo tumor suppressor pathway [23] .
We examined whether RASSF1A may be a substrate of NDR or MST1. The direct phosphorylation of MBP-RASSF1A fusion protein in in vitro kinase assays with the wild-type or kinase dead variants revealed a marked effect of MST1 but not of NDR1 ( Figure S2E ). We then mutated two putative phosphorylation sites in the MBP-RASSF1A construct ( Figure 2D, top) . MST1 efficiently phosphorylated MBP-RASSF1A, whereas MBP-RASSF1A Thr/Ala 202 Ser/Ala 203 displayed only a residual signal ( Figure 2D, bottom) . To investigate the effects of putative RASSF1A phosphorylation in vivo, mutant RASSF1A was expressed along with the wild-type species. Interestingly, analysis of NDR Thr444/442 phosphorylation demonstrated a reduced capacity of the RASSF1A mutant to activate NDR1/2 ( Figure 2E ). It has been reported previously that overexpression of RASSF1A is sufficient to induce apoptosis [4, 7, 8] . We found that the mutant RASSF1A was less potent in triggering apoptosis than the wild-type protein ( Figure 2F ). MST1 and RASSF1A form a complex via association of their SARAH domains [24] . This interaction could facilitate MST1-mediated RASSF1A phosphorylation upon induction of apoptosis [25] . The same motif (Thr   202   Ser 203 ) was previously shown to be targeted by Aurora-A [26] and CDK4 [27] . However, phosphorylation of RASSF1A by these kinases results mostly in effects on the cell cycle and no apoptotic function has been proposed.
Previously, we established that full activation of NDR1/2 depends on the MOB1 coactivator, which elicits its effect through direct binding to the N termini of NDR1 and NDR2 [14, 28] . Human MOB1 protein exists in two isoforms that share more than 95% sequence similarity: MOB1A and B (collectively termed as MOB1 hereafter). In order to study the role of MOB1 in NDR activation during apoptosis, we knocked down both MOB1 isoforms in HeLa cells and treated with the Fas antibody. In these experimental settings, a decrease in MOB1 protein level correlated with reduced Thr444/442 phosphorylation of NDR1/2 ( Figure 3A) . Further, coexpression of MOB1A and MST1 resulted in enhanced NDR1 activity ( Figure 3B ). In vitro kinase assays with MBP-NDR1 as a substrate revealed a stimulatory effect of MOB1A on MST1-induced NDR phosphorylation ( Figure S3A ).
We showed earlier that MOB1A binds to NDR1 kinase and that this association is increased upon okadaic acid (OA) treatment, which preferentially inhibits protein phosphatase 2A [14] . Recent studies also demonstrated association of Drosophila Mats (MOB) and Warts/Lats (LATS) when Mats is phosphorylated by Hpo (MST) [29] . Based on these results, we examined whether human MOB1A and MST1 interact in the presence of OA. Indeed, MOB1A, MST1, and activated NDR1/2 were found in a complex upon OA treatment ( Figures  S3B and S3C) . Moreover, all three proteins displayed cytoplasmic colocalization visualized by confocal microscopy ( Figure 3C, top) . The inducible knockdown of MOB1 almost completely abolished binding between endogenous MST1 and HA-NDR1 (Figure 3C, bottom) .
Because Fas receptor stimulation activated both MST1 and NDR1/2, we examined whether this stimulus could serve as a physiological signal for complex formation. Indeed, we observed association of endogenous MOB1-MST1-NDR proteins, triggered by the Fas antibody treatment. In addition, shRNA against MOB1 was sufficient for disruption of the complex ( Figure 3D ), implying that MOB1 was its driving force. Our results support a model in which MOB1 binding not only releases the autoinhibitory conformation of NDR1/2 [14, 30] , but also promotes maximal activation by inducing a triple complex formation, essential for MST1-mediated phosphorylation. During the preparation of this manuscript, a report was published that describes the association between MST2, MOB1, and NDR1 [31] . However, it is not known whether these proteins form an endogenous complex or which physiological stimulus is required for this association.
Given that activation of NDR1/2 occurred in response to death receptor stimulation and involved several prominent proapoptotic molecules, we were prompted to investigate the functional relevance of NDR1/2 in the apoptotic process. To address this issue, we made use of HeLa cells expressing inducible shRNA directed against NDR1/2. Cells depleted of NDR1/2 were more resistant in developing morphological signs of apoptosis such as membrane blebbing and cellular shrinkage upon addition of the Fas antibody ( Figure 4A, top) . In the same experimental settings, knockdown of NDR1/2 resulted in a significant reduction of cleaved PARP and cytochrome c release in cells undergoing apoptosis ( Figure 4A, bottom) . The proapoptotic effect of NDR1/2 was further confirmed by assessing the mitochondrial membrane potential (DJ), which is a critical factor in the irreversible phase of apoptosis. Loss of DJ induced by the Fas antibody was significantly lower in cells depleted of NDR1/2 than in control HeLa cells ( Figure 4B ). Transient knockdown of NDR1/2 in HeLa and MCF7 cells had a similar effect (Figures S4A and S4B) . The expression of siRNA-resistant wild-type NDR1 or NDR2 allowed Fas-induced apoptosis, whereas reintroduction of siRNAresistant kinase dead (or even more so Thr444Ala) mutants did not restore efficient induction of apoptosis ( Figure 4C ). These data confirm that phosphorylation of the hydrophobic motif as part of NDR activation mechanism is crucial for proapoptotic function of NDR kinases. In addition, it shows that both NDR1 and NDR2 isoforms mediate Fas-induced apoptosis.
We addressed the relevance of NDR1/2 for RASSF1A-mediated apoptosis. Even though both NDR1/2 knockdown and control cells expressed comparable RASSF1A levels, apoptosis was not efficiently induced in the absence of NDR1/2, indicating that these kinases are essential for RASSF1A-mediated cell death ( Figure 4D ). Overexpression of NDR1 significantly enhanced the release of the apoptotic markers, in particular cytochrome c ( Figure S4C, top) , and further potentiated apoptosis triggered by the Fas antibody ( Figure S4C, bottom) . Furthermore, overexpression of NDR1wt but not NDR1Thr444Ala mutant promoted apoptosis in MCF7 cells ( Figure S4D ). Significantly, depletion of endogenous MOB1 resulted in similar reduction in apoptotic response as knockdown of NDR ( Figures  S4A and S4B ). Our data identify NDR1/2 as key apoptotic players downstream of RASSF1A/MST1/MOB1 and provide evidence for this novel NDR kinase function, as summarized schematically in Figure 4F .
Our results, together with the data on MST2-mediated activation of LATS [8, 10] , suggest that the analog of the Hippo pathway in mammals splits at the level of MST kinases to activate LATS and NDR.
Whereas MST1 and 2 have been assigned a proapoptotic function and MOB1 and LATS1/2 are known tumor suppressors [32] [33] [34] , the possible involvement of NDR1/2 in cell transformation has not yet been addressed. The pathway we describe highlights the importance of NDR1/2 in the regulation of apoptosis and contributes to the mechanism of death receptor signaling, which is a part of antitumor defense and is often compromised in cancer. 
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